ITRM920223A0 - Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf. - Google Patents
Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf.Info
- Publication number
- ITRM920223A0 ITRM920223A0 IT92RM223A ITRM920223A ITRM920223A0 IT RM920223 A0 ITRM920223 A0 IT RM920223A0 IT 92RM223 A IT92RM223 A IT 92RM223A IT RM920223 A ITRM920223 A IT RM920223A IT RM920223 A0 ITRM920223 A0 IT RM920223A0
- Authority
- IT
- Italy
- Prior art keywords
- antibodies
- idiopic
- directed against
- tnf
- antibodies directed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM920223A IT1254315B (it) | 1992-03-27 | 1992-03-27 | Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf. |
| EP19930830121 EP0568500A1 (en) | 1992-03-27 | 1993-03-26 | Anti-idiotype monoclonal antibodies directed against anti-TNF antibodies |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM920223A IT1254315B (it) | 1992-03-27 | 1992-03-27 | Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITRM920223A0 true ITRM920223A0 (it) | 1992-03-27 |
| ITRM920223A1 ITRM920223A1 (it) | 1993-09-27 |
| IT1254315B IT1254315B (it) | 1995-09-14 |
Family
ID=11400882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITRM920223A IT1254315B (it) | 1992-03-27 | 1992-03-27 | Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf. |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0568500A1 (it) |
| IT (1) | IT1254315B (it) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9225448D0 (en) * | 1992-12-04 | 1993-01-27 | Erba Carlo Spa | Improved synthesis of polymer bioactive conjugates |
| AT409086B (de) * | 1999-11-16 | 2002-05-27 | Igeneon Krebs Immuntherapie | Neue verwendung von antikörpern als impfstoffe |
| CN101802005B (zh) * | 2007-08-28 | 2015-09-16 | 艾伯维生物技术有限公司 | 包括关于阿达木单抗的结合蛋白质的组合物和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0429484A1 (en) * | 1988-07-26 | 1991-06-05 | VERIGEN, INC. (a Corporation of Delaware) | Porcine polyclonal and monoclonal antibodies |
| EP0608212A1 (en) * | 1990-08-27 | 1994-08-03 | Peptide Technology Ltd | Method of treating viral infection |
| GB9028123D0 (en) * | 1990-12-28 | 1991-02-13 | Erba Carlo Spa | Monoclonal antibodies against human tumor necrosis factor alpha |
| DE07012625T1 (de) * | 1991-03-18 | 2010-01-21 | New York University | Monoklonale und chimäre Antikörper gegen humanen Tumornekrosefaktor |
| WO1993001211A1 (en) * | 1991-07-05 | 1993-01-21 | Peptide Technology Limited | Peptide which abrogates tnf and/or lps toxicity |
| EP0525570A3 (en) * | 1991-07-31 | 1993-10-06 | Miles Inc. | Anti-idiotypic antibodies that mimic tnf |
-
1992
- 1992-03-27 IT ITRM920223A patent/IT1254315B/it active
-
1993
- 1993-03-26 EP EP19930830121 patent/EP0568500A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ITRM920223A1 (it) | 1993-09-27 |
| IT1254315B (it) | 1995-09-14 |
| EP0568500A1 (en) | 1993-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1516629T3 (da) | Humaniseret anti-CD-11a antibodies | |
| DE68914244D1 (de) | Monoklonaler Antikörper. | |
| CY2006001I1 (el) | Ανθρωποποιημενο heregulin αντισωμα | |
| DK145493D0 (da) | Antistof | |
| PT719859E (pt) | Anticorpo monoclonal anti-alfa v-integrina | |
| NO924279D0 (no) | Lyofilisert, monoklonalt antistoffpreparat | |
| DE3854502D1 (de) | Gegen hiv-antigene spezifischer monoklonaler antikörper. | |
| EP0676966A4 (en) | Antibodies directed against binding associated epitopes. | |
| DE3885355D1 (de) | Monoklonale Antikörper. | |
| EP0578515A3 (en) | Humanized monoclonal antibodies. | |
| DE69738312D1 (de) | Hepatitis b monoklonale antikörper | |
| NO920523L (no) | Ige-reseptor-antistoff | |
| TR199501542A2 (tr) | Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari. | |
| DE3780256D1 (de) | Anti-pci-monoklonaler antikoerper. | |
| IT8721163A0 (it) | Anticorpi monoclonali contro flagelli di pseudomonas aeruginosa. | |
| ITRM920223A0 (it) | Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf. | |
| DK49291A (da) | Gramnegativ-bakterieendotoxinblokerende, monoklonale antistoffer | |
| DE3785795D1 (de) | Monoklonale anti-menschliche magenkrebs-antikoerper. | |
| NO873488D0 (no) | Monoklonale antistoffer. | |
| NO890116D0 (no) | Monoklonale antistoffer. | |
| ITMI910491A0 (it) | Immonotossina da anticorpi monoclonali anti-cds | |
| DE69023717D1 (de) | Monoklonaler Antikörper. | |
| FI893928A (fi) | Monoklonala motkroppar. | |
| IT8821702A0 (it) | Nuovo anticorpo monoclonale. | |
| EP0654532A4 (en) | ANTIMUCOGLYCOPROTEIN MONOCLONAL ANTIBODIES. |